0 CHECKOUT

Alaska; Appropriations; General Obligation; Moral Obligation Nov 10

  • ID: 2042096
  • November 2010
  • Region: Alaska
  • Standard & Poors
1 of 3

Abstract
Standard & Poor's Ratings Services assigned its 'AA+' rating, and stable outlook, to the state of Alaska's $200 million series 2010A (taxable Build America bonds-direct payment), series 2010B (taxable qualified school construction bonds- direct payment), and general obligation (GO) bonds series 2010C. At the same time, Standard & Poor's affirmed its 'AA+' rating on the state's GO bonds outstanding, which are backed by the full faith and credit of the state. Standard & Poor's also affirmed its 'AA' ratings on various bonds secured by state lease appropriation ratings, and its 'A+' rating on various bonds secured by a state moral obligation. The GO rating reflects what we view as Alaska's: Strong financial management, with very significant financial reserves and generally...

Companies mentioned in this report are:
- Alaska

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Alaska

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.